Q2 2025

Filed Aug 14, 2025 · 10-Q · 45 days after period end · 0001654954-25-009650

Q2 2025 · 10-Q

Revenue

$53.40K

— vs Q2 2024

Net Income

-$1.64M

N/M vs Q2 2024

EPS Diluted

-$0.43

N/M vs Q2 2024

Gross Profit$17,922—

Operating Income

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	$53.40K	$0.00	$4.05K	$0.00
Net Income	-$1.64M	-$8.24M	-$2.07M	-$2.07M
EPS Diluted	-$0.43	-$2.78	—	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR